Drug intelligence / Profile preview

MenoGynial PLUS

Development stage: Unknown
Lead developer: Gynial
Modality: Small Molecules
Administration: Oral

Overview

MenoGynial PLUS is a hormone-free dietary supplement developed by Gynial GmbH to support women's health during the menopausal transition. It contains a complex of plant-based active ingredients, including 125 mg of isoflavones derived from red clover and fermented soy (providing equol), hop flower extract, sage leaf extract, yam root extract, chamomile flower extract, zinc, and vitamin B6. The supplement is designed to alleviate common menopausal symptoms such as hot flashes and night sweats while supporting hormonal balance and the nervous system. It is administered orally as a once-daily vegan capsule and is formulated to be lactose-free and gluten-free.

Brand names: MenoGynial PLUS

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on MenoGynial PLUS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MenoGynial PLUS.

Explore the full profile